{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:28:36Z","timestamp":1762507716250,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T00:00:00Z","timestamp":1556064000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the National Key R&D Program of China","award":["No.2017YFC1200503"],"award-info":[{"award-number":["No.2017YFC1200503"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No.81470320"],"award-info":[{"award-number":["No.81470320"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biotechnol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12896-019-0514-x","type":"journal-article","created":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T05:38:13Z","timestamp":1556084293000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Efficient gene transfer into T lymphocytes by fiber-modified human adenovirus 5"],"prefix":"10.1186","volume":"19","author":[{"given":"Yun","family":"Lv","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-Jun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Hui","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuo-Zhuang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,24]]},"reference":[{"key":"514_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/978-1-4939-2809-5_3","volume":"1323","author":"T Ciucci","year":"2016","unstructured":"Ciucci T, Vacchio MS, Bosselut R. Genetic tools to study T cell development. Methods Mol Biol. 2016;1323:35\u201345. \n                    https:\/\/doi.org\/10.1007\/978-1-4939-2809-5_3\n                    \n                  .","journal-title":"Methods Mol Biol"},{"key":"514_CR2","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1017\/erm.2015.14","volume":"17","author":"AC Field","year":"2015","unstructured":"Field AC, Qasim W. Engineered T cell therapies. Expert Rev Mol Med. 2015;17:e19. \n                    https:\/\/doi.org\/10.1017\/erm.2015.14\n                    \n                  .","journal-title":"Expert Rev Mol Med"},{"key":"514_CR3","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.omtm.2018.01.010","volume":"8","author":"MC Milone","year":"2018","unstructured":"Milone MC, Bhoj VG. The pharmacology of T cell therapies. Mol Ther Methods Clin Dev. 2018;8:210\u201321. \n                    https:\/\/doi.org\/10.1016\/j.omtm.2018.01.010\n                    \n                  .","journal-title":"Mol Ther Methods Clin Dev"},{"key":"514_CR4","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.3389\/fmicb.2017.02091","volume":"8","author":"DK Wijesundara","year":"2017","unstructured":"Wijesundara DK, Ranasinghe C, Grubor-Bauk B, Gowans EJ. Emerging Targets for Developing T Cell-Mediated Vaccines for Human Immunodeficiency Virus (HIV)-1. Front Microbiol. 2017;8:2091. \n                    https:\/\/doi.org\/10.3389\/fmicb.2017.02091\n                    \n                  .","journal-title":"Front Microbiol"},{"key":"514_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4161\/hv.7.1.12848","volume":"7","author":"MC Johnson","year":"2011","unstructured":"Johnson MC, Wang B, Tisch R. Genetic vaccination for re-establishing T-cell tolerance in type 1 diabetes. Hum Vaccin. 2011;7:27\u201336.","journal-title":"Hum Vaccin"},{"issue":"2","key":"514_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/biomedicines4020009","volume":"4","author":"Richard Morgan","year":"2016","unstructured":"Morgan RA, Boyerinas B. Genetic modification of T cells. Biomedicines. 2016;4. \n                    https:\/\/doi.org\/10.3390\/biomedicines4020009\n                    \n                  .","journal-title":"Biomedicines"},{"issue":"4","key":"514_CR7","doi-asserted-by":"publisher","first-page":"686","DOI":"10.3390\/ijms18040686","volume":"18","author":"Cyrielle Fougeroux","year":"2017","unstructured":"Fougeroux C, Holst PJ. Future prospects for the development of cost-effective adenovirus vaccines. Int J Mol Sci. 2017;18. \n                    https:\/\/doi.org\/10.3390\/ijms18040686\n                    \n                  .","journal-title":"International Journal of Molecular Sciences"},{"key":"514_CR8","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/cas.13228","volume":"108","author":"Y Yamamoto","year":"2017","unstructured":"Yamamoto Y, Nagasato M, Yoshida T, Aoki K. Recent advances in genetic modification of adenovirus vectors for cancer treatment. Cancer Sci. 2017;108:831\u20137. \n                    https:\/\/doi.org\/10.1111\/cas.13228\n                    \n                  .","journal-title":"Cancer Sci"},{"key":"514_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/hum.2013.2527","volume":"25","author":"RG Crystal","year":"2014","unstructured":"Crystal RG. Adenovirus: the first effective in vivo gene delivery vector. Hum Gene Ther. 2014;25:3\u201311. \n                    https:\/\/doi.org\/10.1089\/hum.2013.2527\n                    \n                  .","journal-title":"Hum Gene Ther"},{"key":"514_CR10","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1182\/blood-2016-04-711580","volume":"128","author":"M Richter","year":"2016","unstructured":"Richter M, Saydaminova K, Yumul R, Krishnan R, Liu J, Nagy EE, et al. In vivo transduction of primitive mobilized hematopoietic stem cells after intravenous injection of integrating adenovirus vectors. Blood. 2016;128:2206\u201317. \n                    https:\/\/doi.org\/10.1182\/blood-2016-04-711580\n                    \n                  .","journal-title":"Blood"},{"key":"514_CR11","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1038\/mtna.2013.11","volume":"2","author":"R Voigtlander","year":"2013","unstructured":"Voigtlander R, Haase R, Muck-Hausl M, Zhang W, Boehme P, Lipps HJ, et al. A Novel Adenoviral Hybrid-vector System Carrying a Plasmid Replicon for Safe and Efficient Cell and Gene Therapeutic Applications. Mol Ther Nucleic Acids. 2013;2:e83. \n                    https:\/\/doi.org\/10.1038\/mtna.2013.11\n                    \n                  .","journal-title":"Mol Ther Nucleic Acids"},{"key":"514_CR12","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/gt.2010.75","volume":"17","author":"JS Gil","year":"2010","unstructured":"Gil JS, Gallaher SD, Berk AJ. Delivery of an EBV episome by a self-circularizing helper-dependent adenovirus: long-term transgene expression in immunocompetent mice. Gene Ther. 2010;17:1288\u201393. \n                    https:\/\/doi.org\/10.1038\/gt.2010.75\n                    \n                  .","journal-title":"Gene Ther"},{"key":"514_CR13","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1056\/NEJMoa1300662","volume":"370","author":"P Tebas","year":"2014","unstructured":"Tebas P, Stein D, Tang WW, Frank I, Wang SQ, Lee G, et al. Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. N Engl J Med. 2014;370:901\u201310. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1300662\n                    \n                  .","journal-title":"N Engl J Med"},{"key":"514_CR14","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1099\/vir.0.000139","volume":"96","author":"C Li","year":"2015","unstructured":"Li C, Guan X, Du T, Jin W, Wu B, Liu Y, et al. Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR\/Cas9. J Gen Virol. 2015;96:2381\u201393. \n                    https:\/\/doi.org\/10.1099\/vir.0.000139\n                    \n                  .","journal-title":"J Gen Virol"},{"key":"514_CR15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2174\/156652311796150363","volume":"11","author":"R Khare","year":"2011","unstructured":"Khare R, Chen CY, Weaver EA, Barry MA. Advances and future challenges in adenoviral vector pharmacology and targeting. Curr Gene Ther. 2011;11:241\u201358.","journal-title":"Curr Gene Ther"},{"key":"514_CR16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2174\/156652307780859062","volume":"7","author":"SK Campos","year":"2007","unstructured":"Campos SK, Barry MA. Current advances and future challenges in Adenoviral vector biology and targeting. Curr Gene Ther. 2007;7:189\u2013204.","journal-title":"Curr Gene Ther"},{"key":"514_CR17","doi-asserted-by":"publisher","first-page":"e1004821","DOI":"10.1371\/journal.ppat.1004821","volume":"11","author":"EJ Kremer","year":"2015","unstructured":"Kremer EJ, Nemerow GR. Adenovirus tales: from the cell surface to the nuclear pore complex. PLoSPathog. 2015;11:e1004821. \n                    https:\/\/doi.org\/10.1371\/journal.ppat.1004821\n                    \n                  .","journal-title":"PLoSPathog"},{"key":"514_CR18","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.tips.2012.04.005","volume":"33","author":"N Arnberg","year":"2012","unstructured":"Arnberg N. Adenovirus receptors: implications for targeting of viral vectors. Trends Pharmacol Sci. 2012;33:442\u20138. \n                    https:\/\/doi.org\/10.1016\/j.tips.2012.04.005\n                    \n                  .","journal-title":"Trends Pharmacol Sci"},{"key":"514_CR19","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1089\/hum.2004.15.1229","volume":"15","author":"P Yotnda","year":"2004","unstructured":"Yotnda P, Zompeta C, Heslop HE, Andreeff M, Brenner MK, Marini F. Comparison of the efficiency of transduction of leukemic cells by fiber-modified adenoviruses. Hum Gene Ther. 2004;15:1229\u201342. \n                    https:\/\/doi.org\/10.1089\/hum.2004.15.1229\n                    \n                  .","journal-title":"Hum Gene Ther"},{"key":"514_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.virusres.2010.08.021","volume":"155","author":"H Matsui","year":"2011","unstructured":"Matsui H, Sakurai F, Katayama K, Kurachi S, Tashiro K, Sugio K, et al. Enhanced transduction efficiency of fiber-substituted adenovirus vectors by the incorporation of RGD peptides in two distinct regions of the adenovirus serotype 35 fiber knob. Virus Res. 2011;155:48\u201354. \n                    https:\/\/doi.org\/10.1016\/j.virusres.2010.08.021\n                    \n                  .","journal-title":"Virus Res"},{"key":"514_CR21","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/jgm.543","volume":"6","author":"M Nilsson","year":"2004","unstructured":"Nilsson M, Ljungberg J, Richter J, Kiefer T, Magnusson M, Lieber A, et al. Development of an adenoviral vector system with adenovirus serotype 35 tropism; efficient transient gene transfer into primary malignant hematopoietic cells. J Gene Med. 2004;6:631\u201341. \n                    https:\/\/doi.org\/10.1002\/jgm.543\n                    \n                  .","journal-title":"J Gene Med"},{"key":"514_CR22","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nm.2270","volume":"17","author":"H Wang","year":"2011","unstructured":"Wang H, Li ZY, Liu Y, Persson J, Beyer I, Moller T, et al. Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14. Nat Med. 2011;17:96\u2013104. \n                    https:\/\/doi.org\/10.1038\/nm.2270\n                    \n                  .","journal-title":"Nat Med"},{"key":"514_CR23","doi-asserted-by":"publisher","first-page":"12109","DOI":"10.1128\/JVI.01370-06","volume":"80","author":"S Tuve","year":"2006","unstructured":"Tuve S, Wang H, Ware C, Liu Y, Gaggar A, Bernt K, et al. A new group B adenovirus receptor is expressed at high levels on human stem and tumor cells. J Virol. 2006;80:12109\u201320. \n                    https:\/\/doi.org\/10.1128\/JVI.01370-06\n                    \n                  .","journal-title":"J Virol"},{"key":"514_CR24","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.virol.2004.07.018","volume":"328","author":"YF Mei","year":"2004","unstructured":"Mei YF, Segerman A, Lindman K, Hornsten P, Wahlin A, Wadell G. Human hematopoietic (CD34+) stem cells possess high-affinity receptors for adenovirus type 11p. Virology. 2004;328:198\u2013207. \n                    https:\/\/doi.org\/10.1016\/j.virol.2004.07.018\n                    \n                  .","journal-title":"Virology"},{"key":"514_CR25","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.exphem.2006.05.005","volume":"34","author":"ZZ Lu","year":"2006","unstructured":"Lu ZZ, Ni F, Hu ZB, Wang L, Wang H, Zhang QW, et al. Efficient gene transfer into hematopoietic cells by a retargeting adenoviral vector system with a chimeric fiber of adenovirus serotype 5 and 11p. Exp Hematol. 2006;34:1171\u201382. \n                    https:\/\/doi.org\/10.1016\/j.exphem.2006.05.005\n                    \n                  .","journal-title":"Exp Hematol"},{"key":"514_CR26","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/sj.cgt.7700806","volume":"12","author":"AV Borovjagin","year":"2005","unstructured":"Borovjagin AV, Krendelchtchikov A, Ramesh N, Yu DC, Douglas JT, Curiel DT. Complex mosaicism is a novel approach to infectivity enhancement of adenovirus type 5-based vectors. Cancer Gene Ther. 2005;12:475\u201386. \n                    https:\/\/doi.org\/10.1038\/sj.cgt.7700806\n                    \n                  .","journal-title":"Cancer Gene Ther"},{"key":"514_CR27","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jviromet.2013.07.052","volume":"194","author":"WF Zhang","year":"2013","unstructured":"Zhang WF, Wu FL, Shao HW, Wang T, Huang XT, Li WL, et al. Chimeric adenoviral vector Ad5F35L containing the Ad5 natural long-shaft exhibits efficient gene transfer into human T lymphocytes. J Virol Methods. 2013;194:52\u20139. \n                    https:\/\/doi.org\/10.1016\/j.jviromet.2013.07.052\n                    \n                  .","journal-title":"J Virol Methods"},{"key":"514_CR28","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/sj.cgt.7701039","volume":"14","author":"Z Ye","year":"2007","unstructured":"Ye Z, Shi M, Chan T, Sas S, Xu S, Xiang J. Engineered CD8+ cytotoxic T cells with fiber-modified adenovirus-mediated TNF-alpha gene transfection counteract immunosuppressive interleukin-10-secreting lung metastasis and solid tumors. Cancer Gene Ther. 2007;14:661\u201375. \n                    https:\/\/doi.org\/10.1038\/sj.cgt.7701039\n                    \n                  .","journal-title":"Cancer Gene Ther"},{"key":"514_CR29","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1158\/1535-7163.MCT-06-0187","volume":"5","author":"MA Tyler","year":"2006","unstructured":"Tyler MA, Ulasov IV, Borovjagin A, Sonabend AM, Khramtsov A, Han Y, et al. Enhanced transduction of malignant glioma with a double targeted Ad5\/3-RGD fiber-modified adenovirus. Mol Cancer Ther. 2006;5:2408\u201316. \n                    https:\/\/doi.org\/10.1158\/1535-7163.MCT-06-0187\n                    \n                  .","journal-title":"Mol Cancer Ther"},{"key":"514_CR30","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1089\/hum.2007.067","volume":"18","author":"EL Weber","year":"2007","unstructured":"Weber EL, Cannon PM. Promoter choice for retroviral vectors: transcriptional strength versus trans-activation potential. Hum Gene Ther. 2007;18:849\u201360. \n                    https:\/\/doi.org\/10.1089\/hum.2007.067\n                    \n                  .","journal-title":"Hum Gene Ther"},{"key":"514_CR31","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/sj.gt.3302562","volume":"12","author":"F Sakurai","year":"2005","unstructured":"Sakurai F, Kawabata K, Yamaguchi T, Hayakawa T, Mizuguchi H. Optimization of adenovirus serotype 35 vectors for efficient transduction in human hematopoietic progenitors: comparison of promoter activities. Gene Ther. 2005;12:1424\u201333. \n                    https:\/\/doi.org\/10.1038\/sj.gt.3302562\n                    \n                  .","journal-title":"Gene Ther"},{"key":"514_CR32","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1002\/jgm.769","volume":"7","author":"FP Dupuy","year":"2005","unstructured":"Dupuy FP, Mouly E, Mesel-Lemoine M, Morel C, Abriol J, Cherai M, et al. Lentiviral transduction of human hematopoietic cells by HIV-1- and SIV-based vectors containing a bicistronic cassette driven by various internal promoters. J Gene Med. 2005;7:1158\u201371. \n                    https:\/\/doi.org\/10.1002\/jgm.769\n                    \n                  .","journal-title":"J Gene Med"},{"key":"514_CR33","first-page":"86","volume":"89","author":"M Serafini","year":"2004","unstructured":"Serafini M, Bonamino M, Golay J, Introna M. Elongation factor 1 (EF1alpha) promoter in a lentiviral backbone improves expression of the CD20 suicide gene in primary T lymphocytes allowing efficient rituximab-mediated lysis. Haematologica. 2004;89:86\u201395.","journal-title":"Haematologica"},{"key":"514_CR34","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1182\/blood.V96.10.3392","volume":"96","author":"P Salmon","year":"2000","unstructured":"Salmon P, Kindler V, Ducrey O, Chapuis B, Zubler RH, Trono D. High-level transgene expression in human hematopoietic progenitors and differentiated blood lineages after transduction with improved lentiviral vectors. Blood. 2000;96:3392\u20138.","journal-title":"Blood"},{"key":"514_CR35","doi-asserted-by":"crossref","first-page":"9706","DOI":"10.1128\/JVI.72.12.9706-9713.1998","volume":"72","author":"I Dmitriev","year":"1998","unstructured":"Dmitriev I, Krasnykh V, Miller CR, Wang M, Kashentseva E, Mikheeva G, et al. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism. J Virol. 1998;72:9706\u201313.","journal-title":"J Virol"},{"key":"514_CR36","doi-asserted-by":"publisher","first-page":"e0147173","DOI":"10.1371\/journal.pone.0147173","volume":"11","author":"YH Shen","year":"2016","unstructured":"Shen YH, Yang F, Wang H, Cai ZJ, Xu YP, Zhao A, et al. Arg-Gly-Asp (RGD)-Modified E1A\/E1B Double Mutant Adenovirus Enhances Antitumor Activity in Prostate Cancer Cells In Vitro and in Mice. PLoS One. 2016;11:e0147173. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0147173\n                    \n                  .","journal-title":"PLoS One"},{"key":"514_CR37","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.molimm.2003.08.006","volume":"40","author":"R Trinh","year":"2004","unstructured":"Trinh R, Gurbaxani B, Morrison SL, Seyfzadeh M. Optimization of codon pair use within the (GGGGS)3 linker sequence results in enhanced protein expression. Mol Immunol. 2004;40:717\u201322.","journal-title":"Mol Immunol"},{"key":"514_CR38","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1073\/pnas.95.5.2509","volume":"95","author":"TC He","year":"1998","unstructured":"He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A. 1998;95:2509\u201314.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"514_CR39","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/s00705-012-1293-z","volume":"157","author":"DL Chen","year":"2012","unstructured":"Chen DL, Dong LX, Li M, Guo XJ, Wang M, Liu XF, et al. Construction of an infectious clone of human adenovirus type 41. Arch Virol. 2012;157:1313\u201321. \n                    https:\/\/doi.org\/10.1007\/s00705-012-1293-z\n                    \n                  .","journal-title":"Arch Virol"}],"container-title":["BMC Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-019-0514-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12896-019-0514-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-019-0514-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T23:08:04Z","timestamp":1587596884000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbiotechnol.biomedcentral.com\/articles\/10.1186\/s12896-019-0514-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,24]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["514"],"URL":"https:\/\/doi.org\/10.1186\/s12896-019-0514-x","relation":{},"ISSN":["1472-6750"],"issn-type":[{"type":"electronic","value":"1472-6750"}],"subject":[],"published":{"date-parts":[[2019,4,24]]},"assertion":[{"value":"9 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Because the ways to get samples have no effect on the health of donors and the samples are not for clinical use, the local ethics committee (Medical ethics committee of affiliated hospital of Qingdao university) agreed to the protocols (Hematopoietic Cell Transduction 2018\u201303) of this project in which oral inform consent is needed. All donors are oral informed in conversation room under video record.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"23"}}